Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in <i>Escherichia coli</i>

Mario F. Feldman, Michael Wacker, Marcela Hernandez, Paul G. Hitchen, Cristina L. Marolda, Michael Kowarik, Howard R. Morris, Anne Dell, Miguel A. Valvano, Markus Aebi

Proceedings of the National Academy of Sciences · 2005 · 455 citations · 22 references

DOIFull text

Open access

Concepts

TL;DR

Campylobacter jejuni possesses a general N‑linked protein glycosylation system that can be functionally transferred to Escherichia coli. The study engineered E. coli so that protein N‑glycosylation and lipopolysaccharide biosynthesis converge at the PglB step. E.

Abstract

Campylobacter jejuni has a general N-linked protein glycosylation system that can be functionally transferred to Escherichia coli. In this study, we engineered E. coli cells in a way that two different pathways, protein N-glycosylation and lipopolysaccharide (LPS) biosynthesis, converge at the step in which PglB, the key enzyme of the C. jejuni N-glycosylation system, transfers O polysaccharide from a lipid carrier (undecaprenyl pyrophosphate) to an acceptor protein. PglB was the only protein of the bacterial N-glycosylation machinery both necessary and sufficient for the transfer. The relaxed specificity of the PglB oligosaccharyltransferase toward the glycan structure was exploited to create novel N-glycan structures containing two distinct E. coli or Pseudomonas aeruginosa O antigens. PglB-mediated transfer of polysaccharides might be valuable for in vivo production of O polysaccharides-protein conjugates for use as antibacterial vaccines.

References

22